Profusa, Inc.

Profusa, Inc. (ticker: PFSA) is a medical technology company focused on implantable continuous biosensing, operating in the digital health and medical devices sector. The company filed its annual report on Form 10-K with the SEC on March 31, 2025, covering fiscal year 2024, under accession number 0001013762-25-004396. Profusa reached public markets via a SPAC merger and has been developing its tissue-integrated sensor platform, which is designed to enable real-time monitoring of biochemical signals within the body. The 10-K reflects the company's continued efforts to advance its biosensor technology toward broader commercial and regulatory milestones. Sign up at SpacDesk for full filing data, sponsor details, and deal history on PFSA and hundreds of other SPAC-linked issuers.